Lung cancer cases are increasing in people who have never smoked, especially in women, a new study by the World Health ...

Researchers from the Francis Crick Institute have found that some particularly aggressive lung cancer cells can develop their ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

Cases of lung cancer in people who've never smoked cigarettes or tobacco are increasing, along with evidence suggesting air ...

Estimated geographical and temporal distribution of lung-cancer incidence varied across the four main subtypes worldwide. Our ...

As monotherapy for treatment of adult patients with advanced NSCLC with activating EGFR exon 20 insertion mutations, after failure of platinum-based therapy.

Preliminary phase 1/1b dose expansion results of the bifunctional EGFR/TGFβ inhibitor ficerafusp alfa (BCA101) with pembrolizumab in patients with squamous cell carcinoma of the anal canal. GOBLET ...

Paclitaxel oral solution versus paclitaxel injection as a second-line therapy in advanced gastric cancer: A randomized, open-label, non-inferiority phase 3 trial. This is an ASCO Meeting Abstract from ...

Background: Despite undergoing surgery and chemoradiotherapy, patients with first primary lung cancer (FPLC) remain at risk for second primary lung cancer (SPLC), which is associated with a poor ...

2Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York. Search for other works by this author on: ...

People taking metformin had a lower risk of the two most common skin cancers However, Black patients were not protected against squamous cell cancer TUESDAY, Jan. 14, 2025 (HealthDay News) -- A ...